Free Trial

MiMedx Group (MDXG) Competitors

MiMedx Group logo
$9.06 -0.18 (-1.95%)
(As of 11/20/2024 ET)

MDXG vs. ATEC, XENT, OFIX, CRY, SIBN, INSP, PRCT, AXNX, NVST, and NARI

Should you be buying MiMedx Group stock or one of its competitors? The main competitors of MiMedx Group include Alphatec (ATEC), Intersect ENT (XENT), Orthofix Medical (OFIX), CryoLife (CRY), SI-BONE (SIBN), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), Axonics (AXNX), Envista (NVST), and Inari Medical (NARI). These companies are all part of the "medical" sector.

MiMedx Group vs.

Alphatec (NASDAQ:ATEC) and MiMedx Group (NASDAQ:MDXG) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, community ranking, analyst recommendations, risk, dividends, media sentiment and valuation.

Alphatec received 284 more outperform votes than MiMedx Group when rated by MarketBeat users. However, 81.82% of users gave MiMedx Group an outperform vote while only 57.72% of users gave Alphatec an outperform vote.

CompanyUnderperformOutperform
AlphatecOutperform Votes
329
57.72%
Underperform Votes
241
42.28%
MiMedx GroupOutperform Votes
45
81.82%
Underperform Votes
10
18.18%

MiMedx Group has a net margin of 23.86% compared to Alphatec's net margin of -31.06%. MiMedx Group's return on equity of 26.21% beat Alphatec's return on equity.

Company Net Margins Return on Equity Return on Assets
Alphatec-31.06% -541.39% -22.99%
MiMedx Group 23.86%26.21%18.15%

MiMedx Group has lower revenue, but higher earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alphatec$572.74M2.46-$186.64M-$1.28-7.76
MiMedx Group$321.48M4.14$58.23M$0.5516.47

Alphatec has a beta of 1.31, indicating that its share price is 31% more volatile than the S&P 500. Comparatively, MiMedx Group has a beta of 1.94, indicating that its share price is 94% more volatile than the S&P 500.

Alphatec presently has a consensus price target of $17.11, suggesting a potential upside of 72.32%. MiMedx Group has a consensus price target of $12.00, suggesting a potential upside of 32.45%. Given Alphatec's higher possible upside, analysts clearly believe Alphatec is more favorable than MiMedx Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alphatec
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.89
MiMedx Group
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Alphatec had 1 more articles in the media than MiMedx Group. MarketBeat recorded 10 mentions for Alphatec and 9 mentions for MiMedx Group. Alphatec's average media sentiment score of 0.91 beat MiMedx Group's score of 0.50 indicating that Alphatec is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alphatec
4 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
MiMedx Group
1 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

66.3% of Alphatec shares are owned by institutional investors. Comparatively, 79.2% of MiMedx Group shares are owned by institutional investors. 22.8% of Alphatec shares are owned by insiders. Comparatively, 1.3% of MiMedx Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

MiMedx Group beats Alphatec on 11 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MDXG vs. The Competition

MetricMiMedx GroupSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$1.36B$4.46B$5.05B$8.87B
Dividend YieldN/A36.76%4.97%4.06%
P/E Ratio16.4714.8997.3414.18
Price / Sales4.1447.261,218.4289.42
Price / Cash49.1452.2233.5132.79
Price / Book7.375.475.805.12
Net Income$58.23M$13.76M$119.07M$225.99M
7 Day Performance-1.84%-1.08%-1.83%-1.32%
1 Month Performance58.95%0.58%-3.64%0.60%
1 Year Performance25.66%50.91%31.62%26.23%

MiMedx Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MDXG
MiMedx Group
3.1237 of 5 stars
$9.06
-1.9%
$12.00
+32.5%
+26.4%$1.36B$321.48M16.47895
ATEC
Alphatec
4.8003 of 5 stars
$9.93
+3.8%
$17.11
+72.3%
-12.7%$1.36B$482.26M0.00700Analyst Forecast
XENT
Intersect ENT
N/A$28.24
flat
N/A+0.0%$954.91M$106.75M-5.90433
OFIX
Orthofix Medical
1.3783 of 5 stars
$18.87
+0.7%
$23.00
+21.9%
+74.4%$715.75M$746.64M0.001,634
CRY
CryoLife
1.2837 of 5 stars
N/AN/AN/A$703.22M$253.23M596.201,200Analyst Forecast
SIBN
SI-BONE
4.3736 of 5 stars
$12.15
-1.4%
$23.00
+89.3%
-32.6%$516.68M$138.89M0.00350Analyst Forecast
Insider Trade
Analyst Revision
INSP
Inspire Medical Systems
4.9104 of 5 stars
$184.88
+5.0%
$233.58
+26.3%
+29.2%$5.28B$624.80M172.781,011Analyst Upgrade
Positive News
Gap Up
PRCT
PROCEPT BioRobotics
1.5867 of 5 stars
$92.70
-0.9%
$89.50
-3.5%
+180.7%$4.88B$136.19M0.00626
AXNX
Axonics
3.2587 of 5 stars
$70.98
flat
$71.00
+0.0%
N/A$3.63B$366.38M-591.45610News Coverage
NVST
Envista
3.6426 of 5 stars
$20.37
+0.5%
$20.71
+1.7%
-14.3%$3.49B$2.57B-2.6212,800
NARI
Inari Medical
3.255 of 5 stars
$49.00
-3.9%
$58.89
+20.2%
-15.9%$2.98B$493.63M0.001,300Insider Trade
Positive News

Related Companies and Tools


This page (NASDAQ:MDXG) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners